Assignee
HENNEPIN HEALTHCARE RES INSTITUTE
US·1 granted patent·4 pending applications·0 citations·filing 2017–2024
Top patents by PatentIndex Score
5 records- 0157US2024247270A1Genetically modified cell lines for metabolic studiesHENNEPIN HEALTHCARE RES INSTITUTE·Filed 2024·Application pending·0 cites
- 0257US2024247269A1Genetically modified cell lines for metabolic studiesHENNEPIN HEALTHCARE RES INSTITUTE·Filed 2024·Application pending·0 cites
- 0337US2020032269A1Genetically modified cell lines for metabolic studiesHENNEPIN HEALTHCARE RES INSTITUTE·Filed 2018·Application pending·0 cites
- 0436US2024344103A1In vitro models for estimating drug dosageHENNEPIN HEALTHCARE RES INSTITUTE·Filed 2022·Application pending·0 cites
- 0519US12070492B2Therapeutic compositions and methods with cytokine signaling immunomodulatorsHENNEPIN HEALTHCARE RES INSTITUTE·Filed 2017·Granted Aug 27, 2024·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when HENNEPIN HEALTHCARE RES INSTITUTE files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →